PAPER Boutajangout A, Ingadottir J, Davies P, Sigurdsson EM
SEARCH RESULTS
331159 RESULTS
PAPER Articus K, Baier M, Tracik F, Kühn F, Preuß UW, Kurz A
A 24-week, multicentre, open evaluation of the clinical effectiveness of the rivastigmine patch in patients with probable Alzheimer's disease.
Int J Clin Pract. 2011 Jul;65(7):790-6. PubMed: 21645184PAPER Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Clos AL, Jackson GR, Kayed R
Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice.
Mol Neurodegener. 2011;6:39. PubMed: 21645391PAPER Pignataro G, Capone D, Polichetti G, Vinciguerra A, Gentile A, Di Renzo G, Annunziato L
Neuroprotective, immunosuppressant and antineoplastic properties of mTOR inhibitors: current and emerging therapeutic options.
Curr Opin Pharmacol. 2011 Aug;11(4):378-94. PubMed: 21646048PAPER Weiner MW, Sadowsky C, Saxton J, Hofbauer RK, Graham SM, Yu SY, Li S, Hsu HA, Suhy J, Fridman M, Perhach JL
Magnetic resonance imaging and neuropsychological results from a trial of memantine in Alzheimer's disease.
Alzheimers Dement. 2011 Jul;7(4):425-35. PubMed: 21646051PAPER Jefferson T, Čaušević M, Auf dem Keller U, Schilling O, Isbert S, Geyer R, Maier W, Tschickardt S, Jumpertz T, Weggen S, Bond JS, Overall CM, Pietrzik CU, Becker-Pauly C
Metalloprotease meprin beta generates nontoxic N-terminal amyloid precursor protein fragments in vivo.
J Biol Chem. 2011 Aug 5;286(31):27741-50. PubMed: 21646356PAPER Gao L, Zeng XN, Guo HM, Wu XM, Chen HJ, Di RK, Wu Y
Cognitive and neurochemical alterations in hyperhomocysteinemic rat.
Neurol Sci. 2011 Jun 7; PubMed: 21647626PAPER Jicha GA
Medical management of frontotemporal dementias: the importance of the caregiver in symptom assessment and guidance of treatment strategies.
J Mol Neurosci. 2011 Nov;45(3):713-23. PubMed: 21647712PAPER Wyss DF, Wang YS, Eaton HL, Strickland C, Voigt JH, Zhu Z, Stamford AW
Combining NMR and X-ray Crystallography in Fragment-Based Drug Discovery: Discovery of Highly Potent and Selective BACE-1 Inhibitors.
Top Curr Chem. 2011 Jun 7; PubMed: 21647837PAPER Midi I, Doǧan M, Pata YS, Kocak I, Mollahasanoglu A, Tuncer N
The effects of verbal reaction time in Alzheimer's disease.
Laryngoscope. 2011 Jul;121(7):1495-503. PubMed: 21647891PAPER Su C, Underwood W, Rybalchenko N, Singh M
ERK1/2 and ERK5 have distinct roles in the regulation of brain-derived neurotrophic factor expression.
J Neurosci Res. 2011 Oct;89(10):1542-50. PubMed: 21647938PAPER Lyons MK
Deep brain stimulation: current and future clinical applications.
Mayo Clin Proc. 2011 Jul;86(7):662-72. PubMed: 21646303PAPER Brown PJ, Devanand DP, Liu X, Caccappolo E,
Functional impairment in elderly patients with mild cognitive impairment and mild Alzheimer disease.
Arch Gen Psychiatry. 2011 Jun;68(6):617-26. PubMed: 21646578PAPER Emery VO
Alzheimer disease: are we intervening too late? Pro.
J Neural Transm. 2011 Sep;118(9):1361-78. PubMed: 21647682Aldo Pagano on RNA polymerase III drives alternative splicing of the potassium channel-interacting protein contributing to brain complexity and neurodegeneration.
COMMENT In agreement with Christian Haass, I recommend prudence in linking, unequivocally, the forced expression of 38A ncRNA to the pathological manifestations of AD. We must be cautious in ascribing to its over-synthesis a causative mechanism of AD onset. In th
Current Filters
No filters selected